Stefania Barruscotti

8PUBLICATIONS
59CO-AUTHORS
Innate immunityAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanofabrication, growth and self assemblyModels of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 26, 2025
Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study).

A Carugno, G Nazzaro, L Argnani

|Sep 23, 2025
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results.

Bianca Maria Piraccini, Stephano Cedirian, Francesca Pampaloni

|Sep 09, 2024
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study.

B M Piraccini, F Pampaloni, S Cedirian

|Apr 12, 2024
Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real-life Italian multicenter observational study of 250 patients.

Gianluca Nazzaro, Andrea Carugno, Paolo Bortoluzzi

|Mar 08, 2021
Slow-growing ulcerated nodule in a congenital melanocytic nevus.

Stefania Barruscotti, Chiara Perugini, Chiara Giorgini

|Jul 27, 2020
A significant reduction in the diagnosis of melanoma during the COVID-19 lockdown in a third-level center in the Northern Italy.

Stefania Barruscotti, Chiara Giorgini, Valeria Brazzelli

Pageof 2

Frequent Collaborators

4 joint publications

Emanuele Trovato

4 joint publications

Paolo Gisondi

3 joint publications

Simone Ribero

3 joint publications

Francesco Bellinato